<DOC>
	<DOCNO>NCT01349556</DOCNO>
	<brief_summary>This research do study whether use topical tretinoin help prevent common rash patient often get take epidermal growth factor inhibitor ( EGFR-I ) medication ascetuximab erlotinib . Patients take EGFR-I medication often develop skin irritation acne-like bump face , chest , area . This rash EGFR-I 's often treated moisturizers topical oral antibiotic . However , yet study look way prevent common side effect occur , topical tretinoin may useful reduce rash . Tretinoin 0.025 % cream approve Food Drug Administration ( FDA ) treatment acne , acne scarring , photodamage . It approve use prevent rash associate EGFR-I 's .</brief_summary>
	<brief_title>Prevention Drug Rash From Certain Cancer Therapies Using Tretinoin Cream</brief_title>
	<detailed_description />
	<mesh_term>Drug-Related Side Effects Adverse Reactions</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<criteria>Age 18 year Scheduled begin treatment EGFR inhibitor drug Pregnant nursing History bleed disorder History keloid large , thick , puffylooking scar last 10 year Used topical retinoids last year ( e.g . tretinoin/RetinA , adapalene/Differin , tazarotene/Tazorac )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>cancer</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>EGFR inhibitor</keyword>
	<keyword>tretinoin</keyword>
	<keyword>EGFRi drug rash</keyword>
</DOC>